David Y Tsai, MD
Hospitalist · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tsai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A120477 · Current
Licensed to practise in California · since 2012 · expires 2028-02-29 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$84,018
Medicare paid this office $84,018 for 287 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $34,289 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 142 | $22,084 | $67 |
| Hospital discharge day management, more than 30 minutes | 162 | $17,553 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $8,894 | $146 |
Who their Medicare patients are
287 Original Medicare patients in 2024. Average age 82 · 85 and older 41% · Women 54% · Also on Medicaid 22% · Health risk score 2.14. At or below the middle of the specialty; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 75% · Chronic kidney disease 49% · Coronary heart disease 45% · Diabetes 44% · Heart failure 41% · Atrial fibrillation 38% · Depression 30% · Dementia 30% · Cancer 24% · Stroke 24% · COPD 23%.
The office billed $316,646, Medicare allowed $109,358 and paid $84,018; for 906 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 287 | 906 | 82 | 2.14 | $316,646 | $84,018 |
| 2023 | 329 | 870 | 80 | 1.86 | $321,466 | $86,990 |
| 2022 | 301 | 962 | 81 | 2.01 | $358,865 | $94,439 |
| 2021 | 297 | 804 | 81 | 2.02 | $287,663 | $77,851 |
| 2020 | 252 | 814 | 80 | 2.11 | $250,546 | $76,768 |
| 2019 | 328 | 1,076 | 80 | 2.27 | $326,005 | $98,757 |
| 2018 | 309 | 953 | 80 | 2.29 | $279,251 | $84,502 |
| 2017 | 315 | 964 | 81 | 2.22 | $285,777 | $89,704 |
| 2016 | 258 | 852 | 78 | 2.06 | $241,364 | $76,001 |
| 2015 | 286 | 1,031 | 81 | 2.12 | $294,528 | $98,574 |
| 2014 | 268 | 946 | 80 | 1.94 | $272,648 | $84,152 |
| 2013 | 71 | 266 | 81 | 2.03 | $67,898 | $19,934 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $36,890 | $109 |
| Hospital discharge day management, more than 30 minutes | 165 | $18,060 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 130 | $17,161 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,236 | $149 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,707 | $114 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 174 | $51,927 | $95 |
| Hospital discharge day management, more than 30 minutes | 147 | $15,783 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,111 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $7,932 | $64 |
| Initial hospital observation care per day, typically 70 minutes | 22 | $3,571 | $162 |
| Hospital observation care on day of discharge | 21 | $1,224 | $56 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $28,731 | $93 |
| Hospital discharge day management, more than 30 minutes | 136 | $14,786 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $13,100 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $12,731 | $64 |
| Initial hospital observation care per day, typically 70 minutes | 28 | $4,698 | $168 |
| Hospital observation care on day of discharge | 23 | $1,564 | $68 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $32,174 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 96 | $15,910 | $67 |
| Hospital discharge day management, more than 30 minutes | 110 | $12,087 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,484 | $184 |
| Initial hospital observation care per day, typically 70 minutes | 21 | $3,055 | $145 |
| Hospital observation care on day of discharge | 17 | $1,098 | $65 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 154 | $40,428 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $21,080 | $65 |
| Hospital discharge day management, more than 30 minutes | 144 | $15,561 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $13,267 | $184 |
| Initial hospital observation care per day, typically 70 minutes | 17 | $2,875 | $169 |
| Hospital observation care on day of discharge | 33 | $2,238 | $68 |
| Follow-up observation care per day, typically 25 minutes | 15 | $1,400 | $67 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $32,299 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 148 | $20,197 | $64 |
| Hospital discharge day management, more than 30 minutes | 142 | $14,594 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,516 | $172 |
| Initial hospital observation care per day, typically 70 minutes | 16 | $2,636 | $165 |
| Hospital observation care on day of discharge | 26 | $1,672 | $64 |
| Follow-up observation care per day, typically 25 minutes | 18 | $1,584 | $66 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 131 | $24,492 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 146 | $22,927 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $17,943 | $179 |
| Hospital discharge day management, more than 30 minutes | 128 | $13,452 | $98 |
| Initial hospital observation care per day, typically 70 minutes | 37 | $6,021 | $163 |
| Follow-up observation care per day, typically 25 minutes | 13 | $2,097 | $66 |
| Hospital observation care on day of discharge | 29 | $1,868 | $64 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 132 | $21,894 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $21,759 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,776 | $175 |
| Hospital discharge day management, more than 30 minutes | 112 | $11,698 | $97 |
| Initial hospital observation care per day, typically 70 minutes | 24 | $3,774 | $157 |
| Hospital observation care on day of discharge | 21 | $1,383 | $66 |
| Follow-up observation care per day, typically 25 minutes | 16 | $1,301 | $65 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 151 | $32,791 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $22,725 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $21,536 | $97 |
| Hospital discharge day management, more than 30 minutes | 117 | $12,216 | $102 |
| Initial hospital observation care per day, typically 70 minutes | 26 | $4,528 | $174 |
| Follow-up observation care per day, typically 25 minutes | 16 | $1,979 | $68 |
| Hospital observation care on day of discharge | 18 | $1,245 | $69 |
2014: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 164 | $27,413 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $16,299 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $15,711 | $92 |
| Hospital discharge day management, more than 30 minutes | 138 | $14,288 | $97 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,428 | $162 |
| Follow-up observation care per day, typically 25 minutes | 18 | $2,005 | $65 |
| Hospital observation care on day of discharge | 23 | $1,500 | $65 |
2013: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $10,304 | $62 |
| Hospital discharge day management, more than 30 minutes | 42 | $3,990 | $93 |
Drugs they prescribed that Part D paid
$23,594
Pharmacies billed $23,594 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (29 of 396) in 2024. Above the middle of the specialty; the typical hospitalist clinician is at 4%.
360 generic and 36 brand-name prescriptions · $23,594 in drug cost · 55 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pantoprazole | 31 | $230 | $7 |
| Ondansetron Odt | 16 | $174 | $11 |
| Metoprolol | 12 | $149 | $12 |
| Hydrocodone-Acetaminophen | 11 | $89 | $8 |
| Atorvastatin | 14 | $84 | $6 |
See all 10 drugs
| Pantoprazole | 31 | $230 | $7 |
| Ondansetron Odt | 16 | $174 | $11 |
| Metoprolol | 12 | $149 | $12 |
| Hydrocodone-Acetaminophen | 11 | $89 | $8 |
| Atorvastatin | 14 | $84 | $6 |
| Ciprofloxacin | 18 | $60 | $3 |
| Prednisone | 13 | $50 | $4 |
| Furosemide | 13 | $50 | $4 |
| Clopidogrel | 12 | $42 | $4 |
| Spironolactone | 11 | $15 | $1 |
Year by year
| 2024 | 396 | 131 | 7% (29) | 9% | $23,594 |
| 2023 | 284 | 126 | 8% (23) | None | $11,156 |
| 2022 | 241 | 115 | 7% (16) | None | $9,773 |
| 2021 | 302 | 121 | 9% (26) | 15% | $16,607 |
| 2020 | 280 | 103 | 8% (22) | None | $11,409 |
| 2019 | 227 | 96 | 6% (14) | None | $11,085 |
| 2018 | 207 | 91 | 9% (19) | None | $9,786 |
| 2017 | 268 | 80 | 7% (18) | 18% | $19,248 |
| 2016 | 206 | 74 | 10% (20) | None | $14,102 |
| 2015 | 235 | 80 | 8% (19) | 18% | $10,538 |
| 2014 | 214 | 81 | 12% (25) | 21% | $13,348 |
| 2013 | 511 | 54 | 5% (23) | 15% | $16,929 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Pantoprazole | 12 | $197 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $94 | $8 |
2022: 5 drugs
| Pantoprazole | 11 | $127 | $12 |
| Atorvastatin | 11 | $86 | $8 |
| Amlodipine Besylate | 17 | $83 | $5 |
| Hydrocodone-Acetaminophen | 11 | $78 | $7 |
| Ciprofloxacin | 15 | $74 | $5 |
2021: 6 drugs
| Eliquis | 14 | $7,396 | $528 |
| Pantoprazole | 22 | $280 | $13 |
| Ciprofloxacin | 14 | $110 | $8 |
| Hydrocodone-Acetaminophen | 11 | $96 | $9 |
| Furosemide | 15 | $63 | $4 |
| Prednisone | 11 | $53 | $5 |
2020: 5 drugs
| Hydrocodone-Acetaminophen | 18 | $199 | $11 |
| Pantoprazole | 14 | $111 | $8 |
| Atorvastatin | 12 | $83 | $7 |
| Furosemide | 11 | $41 | $4 |
| Ciprofloxacin | 11 | $41 | $4 |
2019: 2 drugs
| Atorvastatin | 16 | $145 | $9 |
| Furosemide | 16 | $53 | $3 |
2018: 5 drugs
| Eliquis | 11 | $3,930 | $357 |
| Pantoprazole | 14 | $153 | $11 |
| Hydrocodone-Acetaminophen | 11 | $113 | $10 |
| Ciprofloxacin | 13 | $82 | $6 |
| Prednisone | 17 | $80 | $5 |
2017: 4 drugs
| Pantoprazole | 25 | $275 | $11 |
| Atorvastatin | 18 | $162 | $9 |
| Clopidogrel | 19 | $103 | $5 |
| Furosemide | 19 | $58 | $3 |
2016: 3 drugs
| Hydrocodone-Acetaminophen | 11 | $112 | $10 |
| Ciprofloxacin | 12 | $70 | $6 |
| Furosemide | 13 | $48 | $4 |
2015: 2 drugs
| Pantoprazole | 15 | $204 | $14 |
| Atorvastatin | 12 | $118 | $10 |
2014: 3 drugs
| Levofloxacin | 14 | $201 | $14 |
| Hydrocodone-Acetaminophen | 12 | $138 | $12 |
| Furosemide | 20 | $61 | $3 |
2013: 16 drugs
| Clopidogrel | 13 | $1,189 | $91 |
| Atorvastatin | 28 | $1,054 | $38 |
| Benazepril | 32 | $365 | $11 |
| Metformin | 29 | $320 | $11 |
| Carvedilol | 20 | $297 | $15 |
| Levothyroxine | 23 | $260 | $11 |
| Amlodipine Besylate | 24 | $246 | $10 |
| Omeprazole | 17 | $245 | $14 |
| Losartan | 25 | $207 | $8 |
| Metoprolol | 25 | $191 | $8 |
| Simvastatin | 18 | $163 | $9 |
| Tramadol | 14 | $153 | $11 |
| Furosemide | 28 | $152 | $5 |
| Alendronate | 13 | $136 | $10 |
| Hydrochlorothiazide | 28 | $114 | $4 |
| Spironolactone | 11 | $78 | $7 |
Money from drug and device companies
$26 in 2024
| 2024 | 1 | 1 | None | $26 |
| 2023 | 1 | 1 | None | $20 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ACADIA Pharmaceuticals | Daybue | $26 | 1 payment
|
See the published payment
| ACADIA Pharmaceuticals | Meals · 2024-10-07 | Daybue | $26 |
See earlier years (2023, 2019)
2023: $20
| Ucb | Fintepla | $20 | 1 payment
|
2019: $20
| Mallinckrodt Enterprises | Ofirmev | $20 | 1 payment
|
Professional record
- NPI
- 1053683334
- Licence
- CA A120477California A120477: Current · expires 2028-02-29
- Trained
- Tufts University School of Medicine, 2009
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2012-02-02
- NPI last updated
- 2021-02-25
- NPI record certified
- 2021-02-25
This is when the NPI record was last certified, not a medical board exam.